| Factor Information | |
|---|---|
| Data ID | 916 |
| Factor | daily steps (steps/d) |
| Description | Increasing physical activity levels is a high priority to optimize long-term health in children with congenital heart disease (CHD). Commercial activity trackers have not been validated in children. |
| Biomarker | NA |
| Classification | C3 (lifestycle factor - exercise habit) |
| Association | |
|---|---|
| Application | risk assessment |
| Objective | assess the validity of physical activity from a commercial activity tracker against a research-grade accelerometer under free living conditions in children with CHD. |
| p Value | <0.001 |
| Conclusion | Commercial activity trackers provide opportunities to remotely monitor physical activity in children with CHD, but absolute values may differ from accelerometers. These findings are important given the increasing emphasis on physical activity promotion and monitoring in children with cardiovascular risk factors. |
| Risk Factor | unknown |
| CHD Type | |
|---|---|
| ID | 148 |
| CHD Type | NA |
| CHD Subtype | NA |
| Reference | |
|---|---|
| PMID | 28347581 |
| Year | 2017 |
| Title | Validity of Commercial Activity Trackers in Children With Congenital Heart Disease. |
| Sample | ||
|---|---|---|
| Population | children | |
| Source | participants | |
| Region | Columbia,Canada | |
| Method | We assessed the association between devices using intraclass correlation coefficients (ICCs) and Bland-Altman plots. Receiver operating curves were used to identify Fitbit step cut points. | |
| Race | North America | |
| Disease History | N/A | |
| Treatment History | N/A | |
| Group | children with congenital heart disease (CHD)(Fitbit devices)(Treatment) | children with congenital heart disease (CHD)(accelerometers)(Control) |
| Number | N/A (total 30) | N/A (total 30) |
| Age | 10-18 years | 10-18 years |
| Gender (Male: Female) | N/A | N/A |
| Marker Level | 10,383±5,321 (Fitbit devices) | 8,141±4,023 (accelerometers) |
